144 related articles for article (PubMed ID: 14720385)
1. [Abnormalities of molecular biology in premalignant lung lesions].
Shao SJ; Wang Y; Yang PM
Ai Zheng; 2004 Jan; 23(1):99-103. PubMed ID: 14720385
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precancerous lesions of 29 lung cancer patients.
Nishisaka T; Takeshima Y; Inai K
Hiroshima J Med Sci; 2000 Jun; 49(2):109-16. PubMed ID: 10920577
[TBL] [Abstract][Full Text] [Related]
3. [Genetic abnormalities in lung cancer and their prognostic implications].
Mitsudomi T; Takahashi T
Gan To Kagaku Ryoho; 1996 Jul; 23(8):990-6. PubMed ID: 8687234
[TBL] [Abstract][Full Text] [Related]
4. Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program.
Baryshnikova E; Destro A; Infante MV; Cavuto S; Cariboni U; Alloisio M; Ceresoli GL; Lutman R; Brambilla G; Chiesa G; Ravasi G; Roncalli M
Clin Cancer Res; 2008 Mar; 14(6):1913-9. PubMed ID: 18347195
[TBL] [Abstract][Full Text] [Related]
5. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
Gradowski JF; Mantha GS; Hunt JL; Dacic S
Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
[TBL] [Abstract][Full Text] [Related]
6. Clinical detection of lung cancer progression markers.
Tockman MS
J Cell Biochem Suppl; 1996; 25():177-84. PubMed ID: 9027616
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications.
Niklinski J; Niklinska W; Chyczewski L; Becker HD; Pluygers E
Eur J Cancer Prev; 2001 Jun; 10(3):213-26. PubMed ID: 11432708
[TBL] [Abstract][Full Text] [Related]
8. [Genomic alterations in preneoplastic lesions].
Gemma A
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2451-7. PubMed ID: 12506466
[TBL] [Abstract][Full Text] [Related]
9. [From dysplasia to cancer: cytologic, histopathologic and molecular aspects].
Vignaud JM
Rev Mal Respir; 1999 Jan; 16 Suppl 3():S107-11. PubMed ID: 10088273
[No Abstract] [Full Text] [Related]
10. The biology of lung cancer including potential clinical applications.
Zöchbauer-Müller S; Minna JD
Chest Surg Clin N Am; 2000 Nov; 10(4):691-708. PubMed ID: 11091920
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
12. [Genetic alteration in lung cancer].
Hashimoto T; Hayashi M; Tsuchiya E
Nihon Rinsho; 2002 May; 60 Suppl 5():78-82. PubMed ID: 12101778
[No Abstract] [Full Text] [Related]
13. Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions.
Tang X; Liu D; Shishodia S; Ozburn N; Behrens C; Lee JJ; Hong WK; Aggarwal BB; Wistuba II
Cancer; 2006 Dec; 107(11):2637-46. PubMed ID: 17078054
[TBL] [Abstract][Full Text] [Related]
14. Tumour biology: senescence in premalignant tumours.
Collado M; Gil J; Efeyan A; Guerra C; Schuhmacher AJ; Barradas M; Benguría A; Zaballos A; Flores JM; Barbacid M; Beach D; Serrano M
Nature; 2005 Aug; 436(7051):642. PubMed ID: 16079833
[TBL] [Abstract][Full Text] [Related]
15. [Lung cancer].
Haugen A
Tidsskr Nor Laegeforen; 1998 Jun; 118(15):2362-5. PubMed ID: 9691805
[TBL] [Abstract][Full Text] [Related]
16. Multi-step evolution of lung cancer.
Braithwaite KL; Rabbitts PH
Semin Cancer Biol; 1999 Aug; 9(4):255-65. PubMed ID: 10448113
[TBL] [Abstract][Full Text] [Related]
17. [Molecular cytopathology of lung cancer--prevalence of genetic alterations and their role in the development of molecular biomarkers].
Grote HJ; Schmiemann V; Böcking A
Verh Dtsch Ges Pathol; 2003; 87():142-9. PubMed ID: 16888906
[TBL] [Abstract][Full Text] [Related]
18. The molecular basis of lung cancer: molecular abnormalities and therapeutic implications.
Massion PP; Carbone DP
Respir Res; 2003; 4(1):12. PubMed ID: 14641911
[TBL] [Abstract][Full Text] [Related]
19. [Molecular biology of lung cancer].
Akita H
Nihon Kokyuki Gakkai Zasshi; 2004 May; 42(5):378-86. PubMed ID: 15168453
[No Abstract] [Full Text] [Related]
20. [New molecular targets in pancreatic cancer].
Torrisani J; Bournet B; Cordelier P; Buscail L
Bull Cancer; 2008 May; 95(5):503-12. PubMed ID: 18541514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
